Y-mAbs Therapeutics, Inc. - COM (YMAB)

Historical Portfolio Holders from Q3 2018 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
24.4M
Holdings value Q2 2024
$294M
Value change Q2 2024
+$14.9M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
95
Number of buys Q2 2024
49
Number of sells Q2 2024
-49
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 24.4M $294M +$14.9M $12.08 95
2024 Q1 23M $374M +$50.2M $16.26 94
2023 Q4 20.2M $138M +$4.22M $6.82 93
2023 Q3 19.7M $107M -$1.39M $5.45 98
2023 Q2 19.5M $132M +$4.78M $6.79 94
2023 Q1 19M $95.4M -$1.13M $5.01 83
2022 Q4 19.2M $93.6M -$55.2M $4.88 88
2022 Q3 23.1M $333M -$15.4M $14.42 90
2022 Q2 24.2M $366M -$5.52M $15.13 87
2022 Q1 21.9M $260M -$16.6M $11.88 83
2021 Q4 25.4M $411M -$18.3M $16.21 88
2021 Q3 26.2M $748M -$509K $28.54 95
2021 Q2 26.1M $886M -$1.16M $33.80 98
2021 Q1 26.3M $796M +$113M $30.24 115
2020 Q4 22M $1.09B +$38.1M $49.51 111
2020 Q3 21.2M $814M +$2.71M $38.39 102
2020 Q2 20.8M $898M +$48.7M $43.20 106
2020 Q1 20M $520M +$15.5M $26.10 77
2019 Q4 19.4M $606M +$185M $31.25 80
2019 Q3 13.1M $341M +$56.1M $26.06 63
2019 Q2 11M $251M +$54.3M $22.87 58
2019 Q1 8.47M $222M -$3.28M $26.21 43
2018 Q4 8.69M $176M +$18.7M $20.34 42
2018 Q3 7.73M $204M +$204M $26.56 38